Cataract

Showing NaN - NaN of 8

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Inflammation Eye, Pain, Postoperative, Cataract Trial in United States (Dexamethasone Ophthalmic Suspension, Vehicle of OCS-01)

Not yet recruiting
  • Inflammation Eye
  • +2 more
  • Dexamethasone Ophthalmic Suspension
  • Vehicle of OCS-01
  • Inglewood, California
  • +11 more
Nov 7, 2023

Cataract Trial in United States (Clobetasol propionate, Vehicle)

Completed
  • Cataract
  • Chandler, Arizona
  • +21 more
Nov 30, 2022

Primary Open-angle Glaucoma, Cataract Trial in United States (CyPass Micro-Stent implanted with CyPass 241-S applier)

Terminated
  • Primary Open-angle Glaucoma
  • Cataract
  • CyPass Micro-Stent implanted with CyPass 241-S applier
  • Cataract surgery
  • Phoenix, Arizona
  • +19 more
Aug 24, 2022

Cataract Trial in United States (Clareon aspheric hydrophobic acrylic monofocal IOL)

Completed
  • Cataract
  • Clareon aspheric hydrophobic acrylic monofocal IOL
  • Fresno, California
  • +15 more
Jul 9, 2020

Cancer, Cataract, Low Bone Mineral Density Trial in Worldwide (Denosumab, Placebo)

Completed
  • Cancer
  • +5 more
  • Denosumab
  • Placebo
  • Anaheim, California
  • +171 more
Apr 19, 2017

Cataract Trial in Austin (Tecnis Multifocal 1-Piece IOL)

Unknown status
  • Cataract
  • Tecnis Multifocal 1-Piece IOL
  • Austin, Texas
    Dell Laser Consultants
Aug 8, 2016

Cataract Trial in United States (OMS302 Solution, OMS302 Mydriatic Solution, OMS302 Anti-inflammatory Solution)

Completed
  • Cataract
  • OMS302 Solution
  • +3 more
  • Chandler, Arizona
  • +23 more
Aug 27, 2014

Postoperative Complications, Cataract Trial in United States (Bromfenac, Placebo)

Completed
  • Postoperative Complications
  • Cataract
  • Birmingham, Alabama
  • +38 more
Mar 13, 2013